Biotech & Pharma News
  • News

Latest Pharmaceutical News

Stay updated with the most recent developments in biotech and pharmaceutical industries

A New Dawn in Ovarian Cancer: Relacorilant Rewrites the Odds!

A New Dawn in Ovarian Cancer: Relacorilant Rewrites the Odds!

Leila CohenJun 2, 2025
The Future is Clair: AI Rewrites Breast Cancer Prediction, Offering Hope Where None Existed

The Future is Clair: AI Rewrites Breast Cancer Prediction, Offering Hope Where None Existed

Benjamin MooreJun 2, 2025
FDA Greenlights Lifeline: ANKTIVA® Unleashed to Rebuild Immune Defenses in Cancer's Toughest Battles

FDA Greenlights Lifeline: ANKTIVA® Unleashed to Rebuild Immune Defenses in Cancer's Toughest Battles

Sophia KimJun 2, 2025
Heart's New Dawn: FDA Approves World-First Circular RNA Drug, HM2002, to Combat Deadly Ischemic Disease

Heart's New Dawn: FDA Approves World-First Circular RNA Drug, HM2002, to Combat Deadly Ischemic Disease

Benjamin MooreJun 2, 2025
Hope Re-Armed: FDA Approves Moderna's Advanced mNEXSPIKE COVID-19 Vaccine!

Hope Re-Armed: FDA Approves Moderna's Advanced mNEXSPIKE COVID-19 Vaccine!

Leila CohenJun 2, 2025
Survival Doubled: Elraglusib Breakthrough Ignites Hope in Pancreatic Cancer Fight!

Survival Doubled: Elraglusib Breakthrough Ignites Hope in Pancreatic Cancer Fight!

Caleb WilsonJun 2, 2025
Shattering Barriers: Sandoz Unleashes Affordable Hope for Millions Battling Bone Disease!

Shattering Barriers: Sandoz Unleashes Affordable Hope for Millions Battling Bone Disease!

Leila CohenJun 2, 2025
Revolution in Breast Cancer: New Drug Slashes Progression by 56%, Offering Unprecedented Hope!

Revolution in Breast Cancer: New Drug Slashes Progression by 56%, Offering Unprecedented Hope!

Charlotte AndersonJun 2, 2025
The Body Becomes the Cure: Myeloid's mRNA CARs Redefine Cancer Fight!

The Body Becomes the Cure: Myeloid's mRNA CARs Redefine Cancer Fight!

Benjamin MooreMay 30, 2025
......

Stay Updated!

Get the latest biotech and pharma news delivered to your inbox.

© 2025 Biotech Intel. All rights reserved.

  • Terms of Service
  • Privacy Policy